The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the intravenous solutions market in recent years?
The increasing prevalence of cancer is expected to propel the growth of the intravenous solutions market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the ability to invade surrounding tissues and spread to other parts of the body. Intravenous solutions are commonly used in cancer treatment to deliver chemotherapy drugs and maintain hydration during therapy. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the intravenous solutions market.
Intravenous Solutions Market Driver: Surgical Procedure Surge Propels Growth In Intravenous Solutions Market
The increasing number of surgical procedures is expected to propel the growth of the intravenous solutions market going forward. Surgical procedures are any medical operations used to treat various diseases and disorders through incisions or other invasive approaches. The intravenous solutions are essential for surgical procedures, offering vital support for hydration, electrolyte balance, medication administration, and emergency interventions. For instance, in September 2023, according to the International Society of Aesthetic Plastic Surgery, a US-based official journal of the International Society of Aesthetic Plastic Surgery, in 2022, plastic surgeons performed approximately 14.9 million surgical and 18.8 million non-surgical procedures worldwide, representing an 11.2% rise in total procedures. Therefore, the increasing number of surgical procedures is driving the growth of the intravenous solutions market.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp
What is the projected market size of the intravenous solutions industry, and how is it expected to grow?
The intravenous solutions market size has grown strongly in recent years. It will grow from $14 billion in 2024 to $15.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to rise in surgical procedures, growing prevalence of chronic diseases, expansion of home healthcare, stringent regulations ensuring product safety, increased focus on patient hydration, global emergency preparedness initiatives.
The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $20.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to population growth and aging, increasing surgical interventions, rising incidence of infectious diseases, telemedicine and remote patient monitoring, focus on preventive healthcare, global health security investments, patient-centric care trends. Major trends in the forecast period include increased demand for parenteral nutrition solutions, rise in adoption of pre-mixed iv solutions, expansion of home infusion therapies, introduction of electrolyte-balanced solutions, introduction of novel drug additives and adjuncts, integration of smart iv systems for monitoring.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp
Who are the key players driving competition in the intravenous solutions market?
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.
What key trends are expected to drive the intrauterine devices market during the forecast period?
Major companies operating in the intravenous solutions market are focused on developing innovative syringes, such as pre-filled and ready-to-administer syringes, to gain a competitive edge in the market. Pre-filled and ready-to-administer syringes are preloaded with medication and designed for immediate use without requiring manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, launched KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. The syringes are made of a transparent, durable polymer material that eliminates the risks associated with glass syringes. The syringes are pre-filled and ready to administer, saving time and reducing medication errors. Rocuronium bromide injection is for intravenous use only. It possesses several vital attributes, including RFID-enabled with KitCheck, the latest kit and tray management technology, intuitive labeling, and a color-coded plunger rod to support rapid identification.
Which key geographies are driving the growth of the intravenous solutions market?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report
What are the key segments driving growth in the intravenous solutions market?
The intravenous solutions market covered in this report is segmented –
1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings
Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465
How is the intravenous solutions market defined, and what are its core characteristics?
Intravenous solutions are sterile liquids administered directly into a patient’s bloodstream, typically for hydration, medication delivery, or nutrient supplementation. They are used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is impossible.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
